Mostrar el registro sencillo del ítem
dc.contributor.author | Van De Pas, Remco | |
dc.contributor.author | Widdowson, Marc-Alain | |
dc.contributor.author | Ravinetto, Raffaella | |
dc.contributor.author | N Srinivas, Prashanth | |
dc.contributor.author | Ochoa Woodell, Theresa Jean | |
dc.contributor.author | Fofana, Thierno Oumar | |
dc.contributor.author | Van Damme, Wim | |
dc.date.accessioned | 2021-12-12T20:24:56Z | |
dc.date.available | 2021-12-12T20:24:56Z | |
dc.date.issued | 2021 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12866/10244 | |
dc.description.abstract | INTRODUCTION: The global COVID-19 vaccine rollout has highlighted inequities in the accessibility of countries to COVID-19 vaccines. Populations in low- and middle-income countries have found it difficult to have access to COVID-19 vaccines. AREAS COVERED: This perspective provides analyses on historical and contemporary policy trends of vaccine development and immunization programs, including the current COVID-19 vaccination drive, and governance challenges. Moreover, we also provide a comparative health system analysis of the COVID-19 vaccine deployment in some countries from different continents. It recommends that the international Access to COVID-19 Tools Accelerator (ACT-A) partnership requires a strong governance mechanism and urgent financial investment. EXPERT OPINION: All WHO member states should agree on technology transfer and voluntary license-sharing via a commonly governed technology access pool and supported by a just Intellectual Property regime. Contextualized, dynamic understandings and country-specific versions of health systems strengthening are needed to improve vaccine equity in a sustainable matter | en_US |
dc.language.iso | eng | |
dc.publisher | Taylor and Francis | |
dc.relation.ispartofseries | Expert Review of Vaccines | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
dc.subject | low-income countries | en_US |
dc.subject | ACT-A | en_US |
dc.subject | capacity development | en_US |
dc.subject | COVID-19 pandemic | en_US |
dc.subject | research & development ecosystem | en_US |
dc.subject | Tanahashi health systems framework | en_US |
dc.subject | technology transfer | en_US |
dc.subject | TRIPS | en_US |
dc.subject | vaccine equity | en_US |
dc.title | COVID-19 vaccine equity: a health systems and policy perspective. | en_US |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | https://doi.org/10.1080/14760584.2022.2004125 | |
dc.relation.issn | 1744-8395 |
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |